Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: A matched pair comparison with tacrolimus alone

Transplantation

Volumn 92, Issue 3, 2011, Pages 366-371

  Uchida, Naoyuki ^a   Wake, Atsushi ^a   Nakano, Nobuaki ^a   Ishiwata, Kazuya ^a   Takagi, Shinsuke ^a   Tsuji, Masanori ^a   Yamamoto, Hisashi ^a   Kato, Daisuke ^a   Matsuno, Naofumi ^a   Masuoka, Kazuhiro ^a   Araoka, Hideki ^a   Asano Mori, Yuki ^a   Izutsu, Koji ^a   Makino, Shigeyoshi ^a,b   Yoneyama, Akiko ^a   Taniguchi, Shuichi ^a  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Cord blood transplantation; Elderly patients; GVHD prophylaxis; Mycophenolate mofetil; Tacrolimus

Indexed keywords

BUSULFAN; ETOPOSIDE; FLUDARABINE; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THIOTEPA;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CHEMOPROPHYLAXIS; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; INFECTION; LYMPHOMA; MALE; MONOTHERAPY; MORTALITY; MYELODYSPLASTIC SYNDROME; OVERALL SURVIVAL; PILOT STUDY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; WHOLE BODY RADIATION;

ACUTE DISEASE; AGE FACTORS; AGED; CHRONIC DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DATABASES, FACTUAL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; MYCOPHENOLIC ACID; PILOT PROJECTS; TACROLIMUS;

EID: 79961087757     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318223d7ac     Document Type: Article

References (32)

1. Brunstein CG, Wagner JE. Cord blood transplantation for adults. Vox Sang 2006; 91: 195.
2. Schoemans H, Theunissen K, Maertens J, et al. Adult umbilical cord blood transplantation: A comprehensive review. Bone Marrow Transplant 2006; 38: 83.
3. Uchida N, Wake A, Takagi S, et al. Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases. Biol Blood Marrow Transplant 2008; 14: 583.
4. Miyakoshi S, Yuji K, Kami M, et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 2004; 10: 3586.
5. Kishi Y, Kami M, Miyakoshi S, et al. Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation 2005; 80: 34.
6. Brunstein CG, Barker JN, Weisdorf DJ, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on trans-plantation outcomes in 110 adults with hematologic disease. Blood 2007; 110: 3064.
7. Giaccone L, McCune JS, Maris MB, et al. Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Blood 2005; 106: 4381.
8. Osunkwo I, Bessmertny O, Harrison L, et al. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 2004; 10: 246.
9. Takahashi S, Ooi J, Tomonari A, et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007; 109: 1322.
10. Narimatsu H, Terakura S, Matsuo K, et al. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Bone Marrow Transplant 2007; 39: 31.
11. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611.
12. Sanz GF, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 2001; 98: 2332.
13. Lekakis L, Giralt S, Couriel D, et al. Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies. Bone Marrow Transplant 2006; 38: 421.
14. Culter CM, Stevenson K, Kim HT, et al. Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimusbased GVHD prophylaxis. Bone Marrow Transplant 2011; 46: 659.
15. Lipsky JJ. Mycophenolate mofetil. Lancet 1996; 348: 1357.
16. Bardsley-Elliot A, Noble S, Foster RH. Mycophenolate mofetil: A review of its use in the management of solid organ transplantation. BioDrugs 1999; 12: 363.
17. Jacobson P, Rogosheske J, Barker JN, et al. Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation. Clin Pharmacol Ther 2005; 78: 486.
18. Ballen KK, Spitzer TR, Yeap BY, et al. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 2007; 13: 82.
19. Bolwell B, Sobecks R, Pohlman B, et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil forGVHDprophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 34: 621.
20. Cutler C, Li S, Kim HT, et al. Mucositis after allogeneic hematopoietic stem cell transplantation: A cohort study of methotrexate-and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant 2005; 11: 383.
21. Pohlreich D, Vitek A, Maalouf J, et al. Decreased risk of acute gastrointestinal toxicity when substituting methotrexate with mycophenolate mofetil in the prevention of graft-versus-host disease in stem cell transplantation following myeloablative conditioning regimens. Bone Marrow Transplant 2006; 37: 235.
22. Takagi S, Masuoka K, Uchida N, et al. High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. Br J Haematol 2009; 147: 543.
23. Matsuno N, Wake A, Uchida N, et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood 2009; 114: 1689.
24. Patel KJ, Rice RD, Hawke R, et al. Pre-engraftment syndrome after double-unit cord blood transplantation: A distinct syndrome not associated with acute graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 435.
25. Nash RA, Johnston L, Parker P, et al. A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2005; 11: 495.
26. Barker JN, Davies SM, DeFor T, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: Results of a matched-pair analysis. Blood 2001; 97: 2957.
27. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265.
28. Sorror ML, Giralt S, Sandmaier BM, et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: Combined FHCRC and MDACC experiences. Blood 2007; 110: 4606.
29. Sullivan KM. Graft-versus-host-disease [ed. 4]. Cambridge, MA: Blackwell Science 1999.
30. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695.
31. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
32. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Statistics 1988; 116: 1141.